2012
DOI: 10.1007/s11051-012-1006-2
|View full text |Cite
|
Sign up to set email alerts
|

A simple polyol-free synthesis route to Gd2O3 nanoparticles for MRI applications: an experimental and theoretical study

Abstract: In all kinds of gadolinium based contrast agents, the presence of free gadolinium ions have to be avoided due to the cytotoxicity. The conventional way of producing a gadolinium based contrast agent is to form a chelate, i.e. stabilizing the metal ion using a chelating agent (for example DTPA or DOTA) but recently nanoparticles is an initial step towards biocompatible and directed nanoparticles.The main focus is on a material that in the nearby future will be the core of an The experimental results are suppor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

7
49
2
1

Year Published

2013
2013
2023
2023

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 67 publications
(59 citation statements)
references
References 80 publications
7
49
2
1
Order By: Relevance
“…As plotted in Figure 5B, longitudinal relaxivity of CQD-DTPA-Gd was enhanced linearly along with the increase of equivalent Gd concentration. The longitudinal relaxivity of CQD-DTPA-Gd was calculated to be 56.72 mM -1 s -1 , which is significantly higher than commercially available MRI agent Gadovist (r 1 =4.34 mM -1 s -1 ), recently reported Gd-doped CQDs (r 1 =5.88-11.5 mM -1 s -1 ) ( ) [39], indicating that CQD-DTPA-Gd synthesized in this study holds great potential as T1-weighted MRI contrast agent in clinical application. signaling in cells [42][43][44].…”
Section: Synthesis and Characterization Of Cqd-dtpa-gdmentioning
confidence: 86%
“…As plotted in Figure 5B, longitudinal relaxivity of CQD-DTPA-Gd was enhanced linearly along with the increase of equivalent Gd concentration. The longitudinal relaxivity of CQD-DTPA-Gd was calculated to be 56.72 mM -1 s -1 , which is significantly higher than commercially available MRI agent Gadovist (r 1 =4.34 mM -1 s -1 ), recently reported Gd-doped CQDs (r 1 =5.88-11.5 mM -1 s -1 ) ( ) [39], indicating that CQD-DTPA-Gd synthesized in this study holds great potential as T1-weighted MRI contrast agent in clinical application. signaling in cells [42][43][44].…”
Section: Synthesis and Characterization Of Cqd-dtpa-gdmentioning
confidence: 86%
“…Monoclinic and cubic Gd 2 O 3 nanoparticles are paramagnetic in nature and become antiferromagnetic at a Neel temperature of 17.2 K (Jamnezhad and Jafari 2016). Gd 3? ion in gadolinium oxide possesses seven unpaired electrons in the 4f orbital with an electron spin of 7/2 (Ahren et al 2012). It exhibits a long electronic relaxation time of 10 -8 -10…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, they are chelated to form a stable compound and thereby reduce the toxicity levels. 9 There are various methods to synthesize the gadolinium oxide nanoparticles such as polyol method, 10 co-precipitation method, 11 hydrothermal method, 12 sol-gel method, 13 template-assisted technique, 14 pulsed laser ablation, 15 pulsed electron beam evaporation 16 and mechano-chemical methods. 17 Di®erent morphologies of gadolinium oxide nanoparticles such as nanospheres, 18 nano¯bers, 19 nanotubes/ nanorods 20 and nanoplates 21 can be prepared by controlling the process parameters.…”
Section: Introductionmentioning
confidence: 99%